Fecal Microbiota Transplant National Registry

Purpose

A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness

Conditions

  • Fecal Microbiota Transplantation
  • Clostridium Difficile Infection
  • Gut Microbiome

Eligibility

Eligible Ages
All ages
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Recipient Inclusion Criteria - Ability to give informed consent - Receiving FMT or other gut-related microbiota product within 90 days after providing consent - Access to internet and/or telephone - Donor Inclusion - Ability to give informed consent - Providing stool sample for FMT

Exclusion Criteria

  • Incarceration

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Other
Time Perspective
Prospective

Recruiting Locations

Stanford University
Redwood City 5386834, California 5332921 94063

Sutter Roseville Medical Center
Roseville 5388881, California 5332921 95661
Contact:
Tatiana Vidal

University of California San Francisco
San Francisco 5391959, California 5332921 94115
Contact:
Rachael Delacruz

Yale New Haven Hospital
Hamden 4835654, Connecticut 4831725 06518
Contact:
Candace Cotto, RN

University of Miami, Miller School of Medicine
Miami 4164138, Florida 4155751 33136
Contact:
Priscilla De Fatima Madero

Emory University School of Medicine
Atlanta 4180439, Georgia 4197000 30307
Contact:
Drew Siskin

The University of Chicago
Chicago 4887398, Illinois 4896861 60637
Contact:
Derrick Judkins

Loyola University of Chicago/ Loyola University Medical Center
Maywood 4901514, Illinois 4896861 60153
Contact:
Dejan Micic, M.D.

Indiana University School of Medicine
Indianapolis 4259418, Indiana 4921868 46202
Contact:
Sarah Pardue Brennan, RN CCRP

University of Kansas Medical Center Research Institute
Kansas City 4273837, Kansas 4273857 66160
Contact:
Mollie Jackson, M.D.

Ochsner
New Orleans 4335045, Louisiana 4331987 70121
Contact:
James Gore, M.D.

Boston Children's Hospital
Boston 4930956, Massachusetts 6254926 02115
Contact:
Jenna Simes

Brigham and Women's Hospital
Boston 4930956, Massachusetts 6254926 02115
Contact:
Grace Hardwick

UMass Memorial Health
Worcester 4956184, Massachusetts 6254926 01604
Contact:
Anne Foley

University of Michigan
Ann Arbor 4984247, Michigan 5001836 48109
Contact:
Max Macgregor

Henry Ford Health Hospital
Detroit 4990729, Michigan 5001836 48202
Contact:
El-Nachef, MD

Mayo Clinic - Division of Pediatric Gastroenterology
Rochester 5043473, Minnesota 5037779 55905
Contact:
Mary Manyara

Mayo Clinic
Rochester 5043473, Minnesota 5037779 55905
Contact:
Becky Hofschulte

Rutgers
New Brunswick 5101717, New Jersey 5101760 08901
Contact:
Susan Cataldo

New York University School of Medicine
New York 5128581, New York 5128638 10016
Contact:
Philip Dulock

Weill Cornell Medicine
New York 5128581, New York 5128638 10021
Contact:
Dominique Gay

Icahn School of Medicine at Mount Sinai
New York 5128581, New York 5128638 10029
Contact:
Josephine Mitcham

University of North Carolina
Chapel Hill 4460162, North Carolina 4482348 27599
Contact:
Rachel Cooke

Oregon Health & Science University
Portland 5746545, Oregon 5744337 97239
Contact:
Melissa Hershman, M.D.

University of Wisconsin - Madison
Madison 5261457, Wisconsin 5279468 53705
Contact:
Shelly Zimbric

The Medical College of Wisconsin
Milwaukee 5263045, Wisconsin 5279468 53226
Contact:
Anita Ward

More Details

NCT ID
NCT03325855
Status
Recruiting
Sponsor
American Gastroenterological Association

Study Contact

Sonya Serra, MSc
3019412616
sserra@gastro.org

Detailed Description

This registry will prospectively enroll 4,000 patients who undergo FMT at 75 sites throughout North America. Information on FMT methodology employed (e.g., screening of donor and recipient, preparation, FMT delivery) will be collected from each site. The indication for FMT as well as baseline information on recipient will also be collected. Following FMT, patients will be followed at regular intervals up to 10 years post FMT. This will include follow-up information from the patient's healthcare provider at 1 month, 6 months, 1 year, and 2 years after FMT as well as direct communication with patients at least annually up to 10 years after FMT. Follow-up information collected will be designed to assess potential short-term and long-term safety and effectiveness.